Justine Nasone

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of donor weight and age on bone-marrow stem-cell yield in healthy bone-marrow donors.

Impact of donor weight and age on bone-marrow stem-cell yield in healthy bone-marrow donors.

Journal: Transplantation and cellular therapy

Published: July 06, 2026

Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)

Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)

Journal: Bulletin du cancer

Published: January 26, 2026

Real-world comparison of COBE2991 and LOVO Med devices for the post-thaw washing of peripheral blood stem cells and donor lymphocyte infusions.

Real-world comparison of COBE2991 and LOVO Med devices for the post-thaw washing of peripheral blood stem cells and donor lymphocyte infusions.

Journal: Cytotherapy

Published: September 09, 2025

PRIUM-Cell: In utero myelomeningocele prenatal repair program using mesenchymal stromal cells

PRIUM-Cell: In utero myelomeningocele prenatal repair program using mesenchymal stromal cells

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: July 31, 2025

Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease.

Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease.

Journal: Bone marrow transplantation

Published: April 10, 2025

End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)

End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)

Journal: Bulletin du cancer

Published: February 13, 2025

Safety and efficacy of human umbilical cord-derived mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Safety and efficacy of human umbilical cord-derived mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Journal: Stem cell research & therapy

Published: July 10, 2024

How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?

How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?

Journal: Bone marrow transplantation

Published: December 29, 2023

Allogenic umbilical cord-derived mesenchymal stromal cells improve motor function in prenatal surgical repair of myelomeningocele: An ovine model study.

Allogenic umbilical cord-derived mesenchymal stromal cells improve motor function in prenatal surgical repair of myelomeningocele: An ovine model study.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: March 30, 2023

Biodistribution of allogenic umbilical cord-derived mesenchymal stromal cells after fetal repair of myelomeningocele in an ovine model.

Biodistribution of allogenic umbilical cord-derived mesenchymal stromal cells after fetal repair of myelomeningocele in an ovine model.

Journal: Stem cell research & therapy

Published: January 26, 2022

Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC

Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC

Journal: Bulletin du cancer

Published: January 19, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026